The trademark application THESEUS was filed by Theseus Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 27, 2022, and it was registered by office on January 5, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 3, 2024.
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations, drugs in the nature of medicines, and medical diagnostic reagents, all for the treatment of cancer, diabetes and other related diseases.
The mark was filed in class 42 with Scientific and biomedical research, development, and testing of pharmaceuticals and preparations for the treatment, diagnosis and prophylaxis of cancer and other diseases and development of pharmaceutical preparations and medicines..